• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    AstraZeneca Pharma India Limited — Board Meeting, 11-02-2026: Outcome of Board Meeting

    11-02-2026 | 07:05 pm

    AstraZeneca Pharma India reported strong Q3 FY'25-26 revenue of INR 611.57 Cr, up 39%. Profit after tax was INR 46.54 Cr. The company secured 8 new approvals, reinforcing its leadership across therapy areas with innovative medicines.

    No comments yet. Be the first to comment!

    All announcements from AstraZeneca Pharma India Limited